Skip to main content
Premium Trial:

Request an Annual Quote

In Print: Last Week's Microarray Papers of Note: Aug 19, 2014

Premium

Clinical utility of chromosomal microarray analysis of DNA from buccal cells: detection of mosaicism in three patients.
J Genet Couns. 2014 Aug 15. [Epub ahead of print]
Sdano M, et al.

The authors present three cases of improved diagnosis of mosaic aberrations using buccal specimens for chromosomal microarray analysis. In each case, the aberration was either undetectable in blood or present at such a low level it likely could have gone undetected. These cases highlight the limitations of certain laboratory methodologies for identifying mosaicism.


Pharmacokinetics and pharmacogenomics of daunorubicin in children: a report from the Children's Oncology Group.
Cancer Chemother Pharmacol. 2014 Aug 14. [Epub ahead of print]
Thompson P, et al.

The authors explored the impact of obesity, body composition, and genetic polymorphisms on the pharmacokinetics of daunorubicin in children with cancer. The Affymetrix DMET chip was used for genotyping. They found suggestive associations between FMO3 and GSTP1 haplotypes with daunorubicin PK that could potentially affect efficacy and toxicity.


Genome wide CNV analysis reveals additional variants associated with milk production traits in Holsteins.
BMC Genomics. 2014 Aug 15;15(1):683.
Xu L, et al.

The authors performed a genome-wide association between CNVs and milk production traits in 26,362 Holstein bulls and cows. A total of 99 candidate CNVs were identified using Illumina BovineSNP50 array data, and association tests for each production trait were performed using a linear regression analysis with PCA correlation. They concluded that combining CNV with SNP analyses reveals more genetic variations underlying milk production traits than those revealed by SNPs alone.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.